Quick Takeaways
- Michael M. Abecassis has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $23,417.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Michael M. Abecassis
- Location
- Las Vegas, NV
- Summary
- The estimated net worth of Michael M. Abecassis is at least $23,417 dollars as of 02 Apr 2026. Michael M. Abecassis is the Director of PharmaCyte Biotech, Inc. and owns shares of PharmaCyte Biotech, Inc. (PMCB) stock worth about $23.4K.
- Signature
- /s/ Jeffrey D. Cohan, as Attorney-in-Fact for Michael M. Abecassis
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Michael M. Abecassis and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: PharmaCyte Biotech, Inc. ($23,417).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Michael M. Abecassis
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| PMCB | PharmaCyte Biotech, Inc. | Director | $23,417 | 31 Mar 2026 |
Insider Transactions Reported by Michael M. Abecassis:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.